Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1993 1
1994 1
1996 1
1998 2
2001 1
2006 3
2007 1
2008 2
2009 1
2010 3
2011 2
2012 2
2013 5
2014 2
2016 1
2017 3
2018 4
2019 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
High expression of class III β-tubulin in upper gastrointestinal cancer types.
Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin NC, Simon R, Lang DS, Neubauer E, Göbel C, Heinrich MC, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, Lühr C, Noack M, Reiswich V, Weidemann S, Bockhorn M, Perez D, Izbicki JR, Sauter G, Jacobsen F. Höflmayer D, et al. Among authors: lang ds. Oncol Lett. 2018 Dec;16(6):7139-7145. doi: 10.3892/ol.2018.9502. Epub 2018 Sep 25. Oncol Lett. 2018. PMID: 30546449 Free PMC article.
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
Heumann A, Heinemann N, Hube-Magg C, Lang DS, Grupp K, Kluth M, Minner S, Möller-Koop C, Graefen M, Heinzer H, Tsourlakis MC, Wilczak W, Wittmer C, Jacobsen F, Huland H, Simon R, Schlomm T, Sauter G, Steurer S, Lebok P, Hinsch A. Heumann A, et al. Among authors: lang ds. BMC Cancer. 2018 Jan 5;18(1):37. doi: 10.1186/s12885-017-3956-3. BMC Cancer. 2018. PMID: 29304771 Free PMC article.
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer.
Büscheck F, Zub M, Heumann A, Hube-Magg C, Simon R, Lang DS, Höflmayer D, Neubauer E, Jacobsen F, Hinsch A, Luebke AM, Tsourlakis MC, Sauter G, Huland H, Graefen M, Haese A, Heinzer H, Schlomm T, Clauditz TS, Burandt E, Wilczak W, Steurer S, Minner S. Büscheck F, et al. Among authors: lang ds. Tumour Biol. 2019 Jul;41(7):1010428318824815. doi: 10.1177/1010428318824815. Tumour Biol. 2019. PMID: 31296150 Free article.
39 results